Abnormal Movements of the Face

CHAPTER 9 Abnormal Movements of the Face




Introduction


Like most of our human functions, we take facial movements for granted. Quick, complete, and frequent blinks of the eyelids keep the cornea healthy. Narrowing of the eyelid fissures, or “guarding,” protects an irritated eye. Reflex closure of the lids is a spontaneous reaction to avoid trauma to the eye. However, problems of both overactivity and underactivity of the facial muscles are common. Conditions related to overactivity of the facial muscles include:



Problems of underactivity of the facial muscles are seen as well. A loss of facial expression is seen in patients with many of the myogenic ptoses that we have discussed and in patients with Parkinson’s disease. Facial nerve palsy can occur from a number of conditions and results in typical anatomic and functional abnormalities, including incomplete eye closure and corneal exposure, ectropion, and brow ptosis.


These are situations that an oculoplastic surgeon sees daily in practice. The conditions are easily differentiated on a clinical basis and rarely require any sophisticated testing to confirm your clinical impression. Each condition of overactivity or underactivity requires a different therapeutic approach.


In this chapter, we will review the normal anatomy and function of the facial nerve and the muscles of facial expression. The pathologic conditions involving overactivity and underactivity of the facial muscles will be discussed separately. In each section, the important findings in the history and physical examination will be discussed to help you make the correct diagnosis and formulate an appropriate treatment plan. Lastly, the options for medical and surgical therapies are discussed for each disorder.



Anatomy and function



Facial nerve anatomy


The facial nerve extends from its origin in the brainstem to the innervation of the facial muscles. There are two areas of particular interest to us. The first is the point at which the facial nerve leaves the brainstem in close proximity to the fifth and eighth nerves. The second location is distal to the appearance of the facial nerve trunk in the face anterior to the tragus of the ear. From this point, the facial nerve trunk divides into five branches (Figure 9-1):




These branches innervate groups of the facial muscles selectively. Depending on the cause, facial nerve weakness may involve the entire nerve or individual branches. Bell’s palsy or injury to the nerve proximal to the branching of the facial nerve involves the entire face. Accidental or surgical trauma to the face can result in injury localized to one or more branches. All nerves have the ability to regenerate. Unfortunately, regeneration of the facial nerve after injury frequently occurs in a nonanatomic manner known as aberrant regeneration of the facial nerve. You may see this in a patient after a cheek laceration heals. If you look carefully, you may see that the entire cheek moves as a whole. Similarly, after facial nerve palsy, all branches of the facial nerve will receive the same innervation. Pursing of the lips may also narrow the patient’s palpebral fissure (Figure 9-2).





Overactivity of the facial muscles



Disorders





Hemifacial spasm


Hemifacial spasm is an involuntary movement of one side of the face (Figure 9-4). The movement may be a quick apparent twitch or may be seen as a sustained spasm involving all the facial muscles on the side. The etiology of facial spasm is thought to be vascular compression of the facial nerve where the nerve leaves the brainstem. Frequently, the hemifacial spasm is accompanied by signs of mild facial weakness and aberrant regeneration.




Essential blepharospasm


Essential blepharospasm is an uncontrolled blinking or spasm of both eyes (Figure 9-5). Essential blepharospasm results from progressive degeneration of the central nervous system thought to occur in the basal ganglia. It is most commonly seen in elderly patients. Initially, the disorder may start as increased blinking, but it generally progresses to a more sustained spasm of both eyes with prominent orbital orbicularis and corrugator muscle activity. Abnormal movements of the lower face may be seen in association with essential blepharospasm, known as Meige syndrome (Figure 9-6).





History and physical examination of the overactive face


When diagnosing abnormal movements of the face, you will find that your history taking and physical examination occur at the same time. You will learn to watch the patient as you take the history. As you see the type of spasms occurring, you will be able to tailor your questions to make a diagnosis.


Several factors are important in arriving at the correct diagnosis:



Orbicularis myokymia and tics tend to occur in younger patients. Orbicularis myokymia and hemifacial spasm tend to occur in older adults. Orbicularis myokymia has an abrupt onset and usually lasts less than a week. The onset of facial tics may follow a particular event, and they frequently disappear spontaneously over a variable period of time. Hemifacial spasm and essential blepharospasm generally do not have a specific onset and tend to progress. As you watch the patient, you will be able to get a feel for the character of the movement problem. Is the muscle activity a quick twitch or a sustained spasm? Are you seeing an involuntary muscle activity (myokymia, hemifacial spasm, or blepharospasm), or is the abnormal facial movement the result of a voluntary coordinated movement of a group of muscles (a facial tic)? Most of all, you will want to determine which parts of the face are involved. This leads the way to determining the diagnosis (Box 9-1).



It is helpful to divide the face into four quadrants when evaluating patients with movement abnormalities (Figure 9-7).



First ask yourself, “Is one or are both eyes involved?”


If the answer is one eye, ask yourself, “Is the whole side of the face also involved?” If the eye alone is involved, the problem is probably myokymia. You will then know to ask about stress and fatigue. Frequently, the patient will tell you that this is a very busy time at school or work. Probably you have had an episode of orbicularis myokymia yourself.


If one eye and the whole side of the face are involved, the diagnosis is probably hemifacial spasm. In general, patients with hemifacial spasm are older than 50 years, but this condition can occur in the 40s. Beware of diagnosing hemifacial spasm in a patient younger than 40 years of age. As you initially examine the patient with hemifacial spasm, there may be no apparent abnormal movements. You may notice that, as the patient talks, the spasm starts. This is typical of hemifacial spasm where so-called “cross-talk” of nerve fibers initiates the facial spasm. This phenomenon is bothersome to patients because the spasm often starts when they are talking to friends or business acquaintances. If you suspect hemifacial spasm, but don’t see movements elsewhere on the face, look closely at the chin for dimpling of the mentalis muscle or at the neck for subtle movement of the cervical muscles. You may be able to confirm the diagnosis of hemifacial spasm by asking the patient if the spasm occurs while sleeping. Hemifacial spasm is the only diagnosis where spasms continue in the patient’s sleep.


A tic can involve one side of the face as well. Patients with a unilateral periocular tic show orbital orbicularis activity because it is difficult to lightly blink one eye voluntarily. In most patients, it is easy to identify a tic because the movements seem somewhat bizarre and for some reason you get the idea that the patient is actually doing it. Sometimes I will pass by the examination room a few times to see if the movements are occurring in my absence. Frequently, when I enter the room, the facial movements of the tic will start.


If you have identified spasms in both eyes, the patient has either a form of blepharospasm or a facial tic. If the patient with bilateral eyelid spasms is younger than 50 years old, the diagnosis is probably a tic. In all patients, you should rule out the possibility of a reflex blepharospasm from some cause of ocular irritation. The reflex spasm is usually obvious in a young patient but may be more difficult to identify in an older patient who may have an element of dryness in the eye. Ask if the patient has any sensation of a foreign body or burning in the eye. If there is a question of surface irritation causing the spasm, a drop of topical anesthetic should relieve the spasm. If you remain uncertain about the possibility of a reflex component, try lubricants or punctal plugs.


Essential blepharospasm occurs as a degenerative disorder seen mainly in patients older than 60 years. It may occur in the 50s, however. Initially, essential blepharospasm can start out as increased blinking. Over time, the spasms become more forceful. Typically, the symptoms decrease when the patient is busy with an activity such as work or a hobby. Symptoms seem to be worst when the patient is at rest or while the patient is driving or reading. Frequently patients will note that they pry their eyelids open to be able to drive. Sometimes patients will tell you that their eyes feel much more comfortable if they are just closed. On examination, you will see an increased rate of blinking in the early stages of the disease. Usually the orbital orbicularis muscle will be involved. In later stages, the corrugator muscle will pull the eyebrows toward the midline and spasms will be sustained. Often lower facial involvement will be noted with mild abnormal movements of the face, frequently lip pursing. If present, this lower facial movement will help to confirm the diagnosis of essential blepharospasm. As we said earlier, patients with lower facial involvement and blepharospasm are said to have Meige syndrome.



Treatment of the overactive face



Botulinum toxin


The treatment of facial spasm was revolutionized by the introduction of botulinum toxin (Botox®, Allergan Pharmaceuticals, http://www.botoxmedical.com). The toxin serotype A is produced by Clostridium botulinum and is a potent muscle-paralyzing agent. Subcutaneous injection of botulinum toxin into the eyelids and eyebrow provides symptomatic relief of spasm for 3–6 months, depending on the disease process. Botulinum toxin is the primary treatment of hemifacial spasm and essential blepharospasm.





Hemifacial spasm


If you diagnose hemifacial spasm, you should order a magnetic resonance imaging (MRI) scan of the brain to rule out any mass that may be causing compression of the facial nerve. A mass seen on an MRI scan is very rare. I have seen this only once, in a 20-year-old man with hemifacial spasm caused by an epidermoid tumor of the skull base. His spasm resolved upon removal of the mass. In most cases, the scan will be normal or will show a long dilated basilar artery in proximity to the facial nerve where it exits the brainstem, the so-called dolichoectatic basilar artery.


In healthy patients aged 50–60 years or younger, microvascular decompression of the facial nerve (the Janetta procedure) should be considered. In this low-risk intracranial operation, a pad is placed between the artery and the nerve. The reported success rate for this procedure varies, but can be as high as 75%.


Botulinum toxin is the treatment of choice for most patients with hemifacial spasm. Five units of botulinum toxin are administered subcutaneously in five sites around the periocular region (Figure 9-8). The choice of sites can be individualized after the initial injection. Most patients with hemifacial spasm have an element of facial weakness, making the effects of the injections last longer than for patients with essential blepharospasm; 4–6 months is common. Remind your patients to use artificial tears frequently throughout the day and lubricating ointment at night for the first few weeks after injection to prevent corneal exposure.




Essential blepharospasm


Essential blepharospasm is a difficult disorder to treat completely. Most of your patients will see improvement with either botulinum toxin injections or surgical myectomy, but very few will be completely asymptomatic after treatment. The disease tends to be progressive and becomes a lifelong condition that will affect your patient for the rest of his or her life. I urge all patients to subscribe to the Benign Essential Blepharospasm Research Foundation newsletter (637 North 7th Street, Suite 102, PO Box 12468, Beaumont, TX 77726-2468, USA, bebrf@blepharospasm.org).


No oral medication has been proven to be effective for treatment of essential blepharospasm. Most patients will see considerable improvement from botulinum toxin injections. Initially 5 units of botulinum toxin are administered subcutaneously in five sites in the periocular area (Figure 9-9). Injections are given subcutaneously above and below the medial and lateral canthal tendons. No injection is made within the orbital bony rims. An additional 5 units is given above the head of the brow in the area of the corrugator and procerus muscles. Patients note the effect of the toxin over the following 48 hours. After the first injection, I check the patient in 1 week. After subsequent injections, I don’t see the patient before the next injection unless there is a problem. The effects of botulinum toxin last approximately 3–4 months. In some cases, you can modify the position of the injection to improve the effect or decrease a particular area of weakness (usually the mouth). I generally do not increase the dose. I will cut the dose in half for a patient who seems particularly sensitive.



Botulinum toxin has been used safely for 20 years. Many patients have temporary dryness related to the paralysis of the orbicularis muscle and resultant decreased blinking. Corneal exposure can be avoided by using topical lubricants for the first 2 or 3 weeks after injection. You will notice some loss of animation to the face after botulinum toxin injection, as you would expect. Patients rarely complain of this. You will also notice that the “crow’s feet” and other wrinkles of the skin around the eye diminish as the orbicularis muscle is not pulling on the skin (this is the basis for the use of botulinum toxin injections to eliminate glabellar wrinkles in the patient seeking cosmetic improvement). A small number of patients will get upper eyelid ptosis or double vision secondary to botulinum toxin-induced paresis of the levator muscle or extraocular muscles. Ptosis and diplopia are troublesome side-effects, which may last for 6 weeks, but will resolve completely with time.


Most patients see reduction in the blepharospasm after the initial dose of botulinum toxin. If the injections seem to lose their effectiveness over time, apraxia of eyelid opening may be developing. As you know, during eyelid closure, the orbicularis muscle contracts and the levator muscle relaxes. Although we think of essential blepharospasm as a condition related to spasm of the orbicularis muscle, there is an element of uncontrolled levator muscle relaxation involved as well. Remember that many of your patients with essential blepharospasm may tell you that they feel better with their eyes closed. This is because it is a struggle for them to overcome the inhibition of the levator muscle seen with essential blepharospasm. Early in the disease process, the orbicularis spasm predominates and botulinum toxin reduces the spasm. If apraxia develops, the patient may perceive that the injections are no longer working. If this is the case when you ask the patient to close the eyes, you can see that the orbicularis muscle is still weak and spasm is not the main cause of the inability to open the eyes. Recently some relief of apraxia of eyelid opening has been obtained using frontalis sling surgery.


Surgical myectomy was popularized in the early 1980s before the use of botulinum toxin. In this procedure, the orbital orbicularis, the corrugator, and procerus muscles, and portions of the preseptal and pretarsal orbicularis muscles are resected from the upper eyelid. In addition, anatomic problems related to the constant spasm, such as dermatochalasis, eyelid ptosis, and brow ptosis, can be corrected at the same time. Surgical myectomy has been refined over recent years and remains an option for patients who don’t get a satisfactory effect from botulinum toxin injections. Myectomy does not eliminate apraxia of lid opening, however. Approximately half of all patients undergoing myectomy continue to require botulinum toxin injections postoperatively, often at a reduced dose or frequency. Although the role for surgical myectomy is small, selected patients with essential blepharospasm will benefit from this procedure.





Weakness of the facial muscles



Mar 14, 2016 | Posted by in General Surgery | Comments Off on Abnormal Movements of the Face

Full access? Get Clinical Tree

Get Clinical Tree app for offline access